SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. announced today that it will present at the LD MICRO Conference on Thursday, December 3, 2009 at 2:00 p.m. (PST) at the Luxe Hotel in Los Angeles. Aethlon Medical’s Chairman and CEO, James A. Joyce, will present a corporate overview and will provide an update on the company’s clinical progress for its lead product, the Hemopurifier(R), a first-in-class artificial adjunct to the immune system proven to capture infectious viruses and immunosuppressive particles from the human circulatory system.
The LD MICRO Conference brings together 75 presenting companies with over 100 institutions focused on investing in small and micro cap companies across a breadth of industries.
About LD MICRO
LD MICRO is a by-invitation only newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published an annual list of recommended stocks as well as comprehensive reports on select companies throughout the year. LD MICRO concentrates on finding, researching, and investing in companies that are overlooked by institutional investors. It is a non-registered investment advisor.
Photo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.comAethlon Medical, Inc.
